ACVR2B and anemia: Notably, patient samples of the lower-risk MDS subtypes refractory anemia and refractory anemia with ring sideroblasts, in which anemia is the predominant clinical presentation, have significantly elevated levels of GDF11 and ACVR2B transcripts (Figure 1B).